[ad_1]
Cipla Medpro acquired the pharmaceutical manufacturer and distributor Mirren for R450m.
The agreement aims to help the fourth largest pharmaceutical company in SA to expand its portfolio over the counter.
Paul Miller, CEO of Cipla Medpro, said the transaction would allow the company to challenge Aspen Pharmacare and Adbad, the major players in the over-the-counter market.
"We are not very present in the pain, colds and flu category."
The agreement, which is still subject to regulatory approval, will be financed by debt.
Cipla Medpro, which also distributes antiretroviral drugs to 800,000 HIV patients on a monthly basis, is wholly owned by Cipla India, the global pharmaceutical company
Mirren, which owns brands such as Broncol Cough Syrup, Coryx , Tensopyn and Ultimag, has been in business for 35 years.
"The acquisition by Cipla will help to ensure t" The continued growth that Mirren brands have achieved over the past three years will be maintained, "said the Mirren's director, Lynton Lomas
[ad_2]
Source link
